Dosimetric Analysis of the Short-Ranged Particle Emitter <sup>161</sup>Tb for Radionuclide Therapy of Metastatic Prostate Cancer

Dosimetric Analysis of the Short-Ranged Particle Emitter <sup>161</sup>Tb for Radionuclide Therapy of Metastatic Prostate Cancer

The aim of this study was to analyze the required absorbed doses to detectable metastases (D<sub>req</sub>) when using radionuclides with prostate specific membrane antigen (PSMA)-targeting radioligands to achieve a high probability for metastatic control. The Monte Carlo based analysis...

Full description

Bibliographic Details
Main Authors: Peter Bernhardt, Johanna Svensson, Jens Hemmingsson, Nicholas P. van der Meulen, Jan Rijn Zeevaart, Mark W. Konijnenberg, Cristina Müller, Jon Kindblom
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
dosimetry
prostate cancer
PSMA
<sup>161</sup>Tb
Online Access:https://www.mdpi.com/2072-6694/13/9/2011

Internet

https://www.mdpi.com/2072-6694/13/9/2011

Similar Items